Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting Report

FDOPA and68GaDotatate PET Imaging in Nesidioblastosis

Louise Juanita Nortje, Suleiman Muftah El-Bejou, Younes Mokrab, Ana Isabel Almeida and Mehdi Djekidel
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1142;
Louise Juanita Nortje
1Sidra Medicine Doha Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suleiman Muftah El-Bejou
1Sidra Medicine Doha Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Younes Mokrab
1Sidra Medicine Doha Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Isabel Almeida
1Sidra Medicine Doha Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mehdi Djekidel
1Sidra Medicine Doha Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1142

Introduction: Nesidioblastosis also known as persistent hyperinsulinemic hypoglycemia of infancy or congenital hyperinsulinism occurs most commonly in infants and children. It presents with recurrent episodes of hypoglycemia due to high endogenous insulin levels. There is a focal and diffuse form of the disease depending on the extent of pancreatic involvement. Hyperplasia of the islet cells results in hyperfunctioning pancreatic β cells and the ensuing clinical disease. Medical treatment fails in several patients and surgery has been shown to be very effective in improving prognosis and even resolution of disease in the focal form. Several genetic mutations have been uncovered and these may also be predictive of prognosis. Anatomical imaging alone including ultrasound, CT and MRI are rarely able to detect any abnormality in the pancreas. PET plays a major role in the distinction between the focal and diffuse forms of the disease. It can also guide surgical intervention by providing information on the location of the focal hyperfunctioning islet cells. Imaging children and infants in this disease is quite challenging. We propose to show the benefit of using two PET tracers in this disease. FDOPA has been used quite successfully in the evaluation of nesidioblastosis. 68Ga DOTATATE has also been described to be helpful. We illustrate in 3 scans focal disease in the pancreatic head. Illustrated in Figure 1, in a 2 month old baby boy with nesidioblastosis and a KCNJ 11 genetic mutation we can see the slight difference in visualization of focal pancreatic head uptake in a small baby between both tracers that have a different physiological distribution. 68Ga DOTATATE has more uptake in the kidneys which may affect visualization of lesions in proximity to the kidneys and FDOPA with more uptake in the liver may also pose some challenge in detecting adjacent lesions. In Figure 2 focal uptake in the head of the pancreas is more apparent in an older 6 month old boy with nesidioblastosis. This latter was found to carry a heterozygous pathogenic mutation in the ABCC8 gene.

Conclusions: FDOPA and 68Ga DOTATATE are critical in the evaluation of nesiodioblastosis patients. FDOPA as described in the literature seems to be slightly superior.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
FDOPA and68GaDotatate PET Imaging in Nesidioblastosis
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
FDOPA and68GaDotatate PET Imaging in Nesidioblastosis
Louise Juanita Nortje, Suleiman Muftah El-Bejou, Younes Mokrab, Ana Isabel Almeida, Mehdi Djekidel
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1142;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
FDOPA and68GaDotatate PET Imaging in Nesidioblastosis
Louise Juanita Nortje, Suleiman Muftah El-Bejou, Younes Mokrab, Ana Isabel Almeida, Mehdi Djekidel
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1142;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Rest Dose Spillover Correction of Stress Blood Flow Measurements in Digital Rb-82 Myocardial Perfusion PET/CT Imaging
  • Radiolabeled hyaluronic acid (HA) fragments for lymphatic imaging
  • Simplifying and Confirming Ketosis: A Quality Improvement Initiative in Cardiac Sarcoid Assessment
Show more

Educational Exhibits Poster Session I

  • 5-HT1A/5-HT1B imaging in the evaluation of treatment response in Major Depressive Disorder.
  • Omission errors in PET/CT
  • Pictorial review of parathyroid adenomas on Tc-99m sestamibi SPECT
Show more Educational Exhibits Poster Session I

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire